Traws Pharma, Inc. 8-K Report: Key Updates on Common Stock Events

Here are the key insights extracted from the provided section of the financial report:
- Entity Information:
- Company Name: Traws Pharma, Inc.
- CIK (Central Index Key): 0001130598
- State of Incorporation: Delaware (DE)
- SEC File Number: 001-36020
- EIN (Employer Identification Number): 22-3627252
- Address: 12 Penns Trail, Newtown, PA 18940
- Phone Number: 267-759-3680
- Filing Type:
- Form Type: 8-K (a current report used to announce major events that shareholders should know about).
- Filing Date:
- Date of Filing: December 16, 2024
- Common Stock Details:
- Type of Security: Common Stock
- Par Value: $0.01 per share
- Ticker Symbol: TRAW
- Exchange: NASDAQ
- Reporting Period:
- Report Date: December 16, 2024
- The report covers a single date rather than a range, indicating that it may involve a specific event that occurred on that date.
- Units of Measure:
- The financial information is presented in USD (U.S. Dollars) and shares.
In summary, Traws Pharma, Inc. filed an 8-K report on December 16, 2024, primarily focusing on a specific event related to its common stock, which is traded on NASDAQ under the ticker TRAW. The report includes basic corporate identification and financial details relevant to stakeholders.